EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chemically Modified Thiazole Orange FIT-PNAs: Superior Nucleic Acid Sensing Molecules

Amer Fadila, Pinaki Chanda, Salam Maree, Odelia Tepper, Daniel H. Appella, Hongchao Zheng, Eylon Yavin

Chemical & Biomedical Imaging · 20.08.2026

DOI: 10.1021/cbmi.6c00116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical & Biomedical Imaging, online erschienen am 20.08.2026. Verfasst von Amer Fadila und 6 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Science Foundation, Len & Susan Mark Initiative for Ovarian and Uterine/MMMT Cancers?Phase III, Israel Cancer Research Fund, Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA and DNA biomarkers serve as diagnostic molecules for detecting a specific disease by a variety of methods and technologies. A common approach is based on a fluorescence readout signal generated after hybridization to a target nucleic acid sequence. One such technology is termed Forced-Intercalation Peptide Nucleic Acid (FIT-PNA). In the FIT-PNA design, one of the nucleobases of the PNA sequence is replaced by a fluorescent molecule termed as “surrogate base.” One of the more common fluorophores explored to date is the cyanine dye, Thiazole Orange (TO). In this report, we have designed TO-based FIT-PNAs that are chemically modified with a cyclopentane backbone (cpTO). In addition, we have introduced to the FIT-PNA design either a cyclopentane T (cpT) or a tetrahydrofuran T (THFT) flanking cpTO. In a model system (11-mer FIT-PNA), we observe a dramatic increase in fluorescence (with DNA or RNA complementary sequences) for both cpT-cpTO and THFT-cpTO FIT-PNAs in comparison to the unmodified counterpart (T-TO FIT-PNA). Moreover, sequence specificity for an RNA sequence with a single mismatch is dramatically improved for both cpT-cpTO and THFT-cpTO FIT-PNAs. Molecular simulations of both cpT-cpTO FIT-PNA and TO (unmodified) FIT-PNA further support the superiority of these chemically modified nucleic-acid probes, as corroborated by a greater π–π stacking of cpTO in the PNA-RNA duplex. Lastly, a cpT-cpTO FIT-PNA targeting the oncogenic long noncoding RNA ANRIL (antisense noncoding RNA in the INK4 locus) was shown to detect this RNA biomarker in ovarian cancer cells (OVCAR-8). This probe was superior to the unmodified TO-based FIT-PNA, highlighting the added value of chemically modified TO FIT-PNAs as means for obtaining highly sensitive and sequence-specific nucleic acid sensors.

Förderung

  • Israel Science Foundation
  • Len & Susan Mark Initiative for Ovarian and Uterine/MMMT Cancers?Phase III, Israel Cancer Research Fund
  • Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH)
  • David R. Bloom Center for Pharmacy, Alex Grass Center for Drug Design and Novel Therapeutics

Zitieren

APA

Fadila, A., Chanda, P., Maree, S., Tepper, O., Appella, D. H., Zheng, H., & Yavin, E. (2026). Chemically Modified Thiazole Orange FIT-PNAs: Superior Nucleic Acid Sensing Molecules. Chemical & Biomedical Imaging. https://doi.org/10.1021/cbmi.6c00116

Vancouver

Fadila A, Chanda P, Maree S, Tepper O, Appella DH, Zheng H, et al. Chemically Modified Thiazole Orange FIT-PNAs: Superior Nucleic Acid Sensing Molecules. Chemical & Biomedical Imaging. 2026. doi:10.1021/cbmi.6c00116

BibTeX
@article{Fadila2026,
  author = {Fadila, Amer and Chanda, Pinaki and Maree, Salam and Tepper, Odelia and Appella, Daniel H. and Zheng, Hongchao and Yavin, Eylon},
  title = {Chemically Modified Thiazole Orange FIT-PNAs: Superior Nucleic Acid Sensing Molecules},
  journal = {Chemical & Biomedical Imaging},
  year = {2026},
  doi = {10.1021/cbmi.6c00116}
}
Kostenlos starten →